Molecular Imaging Technologies LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Molecular Imaging Technologies LLC - overview
Established
1997
Location
Blue Bell, PA-Pennsylvania, US
Primary Industry
Medical Devices & Equipment
About
Molecular Imaging Technologies LLC focuses on developing advanced imaging solutions to enhance diagnostic capabilities in healthcare, utilizing technologies such as PET and SPECT for high-resolution imaging. Founded in 1997, Molecular Imaging Technologies LLC is based in Blue Bell, US, specializing in molecular imaging technologies. The company has successfully executed one deal, with its most recent being on September 16, 2020. Molecular Imaging Technologies specializes in advanced imaging solutions designed to enhance diagnostic capabilities in healthcare settings.
Their core offerings include a range of molecular imaging systems that utilize technologies such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). These systems provide high-resolution imaging that enables clinicians to visualize and quantify biological processes at the molecular and cellular levels. The primary end users include hospitals, research institutions, and diagnostic facilities in North America, Europe, and parts of Asia, addressing challenges in early disease detection and treatment monitoring. Molecular Imaging Technologies generates revenue through a combination of direct sales and strategic partnerships with healthcare providers and diagnostic centers.
The revenue model includes the sale of imaging systems alongside ongoing service agreements for maintenance and software upgrades. Customers typically enter into multi-year contracts ensuring access to the latest technological enhancements. Pricing structures are tailored to client needs, with flagship products offered under premium pricing tiers. The company also engages in collaborative projects with research institutions, diversifying its revenue streams through research grants and joint ventures that capitalize on their technological innovations.
In September 2020, Alliance HealthCare Services, Inc. acquired four PET/CT locations owned by Molecular Imaging Technologies LLC. The company plans to leverage this acquisition to enhance its service offerings and expand its reach. Future growth initiatives include launching new imaging products aimed at improving diagnostic accuracy and expanding into additional markets, particularly in Europe and Asia, by 2023.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment
Website
www.molecularimagingtech.com
Total Amount Raised
Subscriber access only
Molecular Imaging Technologies LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Molecular Imaging Technologies LLC | - | ||||||||
| Merger | Completed | Oncology Molecular Imaging, LLC | - |
Displaying 1 - 2 of 2
Molecular Imaging Technologies LLC - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.